Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 1 , Pages 48-55 , January 2009

Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity

References 

  1. Hjalmarson A, Goldstein S, Fagerberg B, et al. MERIT-HF Study Group Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA. 2000;283:1295–1302
  2. Heart Failure Society of America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches. Anonymous Pharmacotherapy. 2000;20:495–522
  3. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)). J Am Coll Cardiol. 1996;28:1328–1428
  4. McMeill RS. Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics. Lancet. 1964;13:1101–1102
  5. Raine JM, Palazzo MG, Kerr JH, Sleight P. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br J Med (Clin Res Ed). 1981;282:548–549
  6. Williams IP, Millard FJ. Severe asthma after inadvertent ingestion of oxprenolol. Thorax. 1980;35:160
  7. Harries AD. Beta-blockade in asthma. Br J Med (Clin Res Ed). 1981;282:1321
  8. Fraunfelder FT, Barker AF. Respiratory effects of timolol. N Engl J Med. 1984;311:1441
  9. Odeh M, Oliven A, Bassan H. Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient. J Fam Pract. 1991;32:97–98
  10. Meeker DP, Wiedemann HP. Drug-induced bronchospasm. Clin Chest Med. 1990;11:165–175
  11. August P. Initial treatment of hypertension. N Engl J Med. 2003;348:610–617
  12. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol. 2001;37:1950–1956
  13. Self T, Soberman JE, Bubla JM, Chafin CC. Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?. J Asthma. 2003;40:839–845
  14. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med. 2002;137:715–725
  15. Menkhaus PG, Reves JG, Kissin I, et al. Cardiovascular effects of esmolol in anesthetized humans. Anesth Analg. 1985;64:327–334
  16. Sheppard D, Distefano S, Byrd RD, et al. Effects of esmolol on airway function in patients with asthma. J Clin Pharmacol. 1986;26:169–174
  17. Gold MR, Dec GW, Cocca-Spofford D, Thompson BT. Esmolol and ventilatory function in cardiac patients with COPD. Chest. 1991;100:1215–1218
  18. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull. 1992;40:1462–1469
  19. Boskabady MH, Adel-Kardan S. Increased muscarinic receptor blockade by atropine in tracheal chains of ovalbumin-sensitized guinea pigs. Pharmacology. 1999;58:300–308
  20. Wu Z-X, Zhou D, Chen G, Lee L-Y. Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea pigs. Am J Respir Crit Care Med. 2000;161:73–80
  21. Toward TJ, Broadley KJ. Early and late bronchoconstrictions, airway hyperreactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin Exp Allergy. 2004;34:91–102
  22. Giles RE, Finkel MP, Mazurowski J. Use of an analog on-line computer for the evaluation of pulmonary resistance and dynamic compliance in the anesthetized dog. Arch Int Pharmacodyn. 1971;194:213–222
  23. Hollenberg M, Mangano DT, Browner WS, London MJ, Tubau JF, Tateo IM. Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery (The Study of Perioperative Ischemia Research Group). JAMA. 1992;268:205–209
  24. Oda Y, Nishikawa K, Hase I, Asada A. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg. 2005;100:733–737
  25. Silvanus M-T, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasms after tracheal intubation. Anesthesiology. 2004;100:1052–1057
  26. Murray JF. History and physical examination. In:  Murray JF,  Nadel JA editor. Textbook of respiratory medicine. Philadelphia: Saunders; 1989;p. 443
  27. Smith H. Animal models of asthma. Pulm Pharmacol. 1989;2:59–74
  28. Kodani M, Sakata N, Takano Y, et al. Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes. Immunopharmacol. 2000;49:263–274
  29. Abe M, Shibata K, Akatsu H, et al. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J Immunol. 2001;167:4651–4660
  30. Hershenson MB, Aghili S, Punjabi N, et al. Hyperoxia-induced airway hyperresponsiveness and remodeling in immature rats. Am J Physiol. 1992;262:L263–L269
  31. Shiroya T, Ichioka Y, Yoshida K, et al. Pharmacological studies of ONO-1101 as a beta-blocking agent with high beta1-selectivity and ultra-short duration of action. KISO TO EINSHO (written in Japanese). 1997;31:2913–2923
  32. Iguchi S, Iwamura H, Nishizaki M. Development of a highly cardioselective ultrashort-acting beta-blocker, ONO-1101. Chem Pharm Bull. 1992;40:1462–1469
  33. Emala CW, Aryana A, Hirshman CA. Impaired activation of adenylyl cyclase in lung of the Besenji-greyhound model of airway hyperresponsiveness: decreased numbers of high affinity beta-adrenoceptors. Br J Pharmacol. 1996;118:2009–2016
  34. Emala CW, Clancy-Keen J, Hirshman CA. Decreased adenylyl cyclase protein and function in airway smooth muscle by chronic carbachol pretreatment. Am J Physiol. 2000;279:C1008–C1015
  35. Pizov R, Brown RH, Weiss YS, et al. Wheezing during induction of general anesthesia in patients with and without asthma (A randomized, blinded trial). Anesthesiology. 1995;82:1111–1116
  36. Volta CA, Alvisi V, Petrini S, et al. The effect of volatile anesthetics on respiratory system resistance in patients with chronic obstructive pulmonary disease. Anesth Analg. 2005;100:348–353
  37. The Esmolol Research Group. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. Am Heart J. 1986;112:498–505
  38. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anesth. 2001;48:985–989
  39. Nakashima M, Kanamaru M. Phase I study ONO-1101, a new ultra short acting beta1-blocking agent in healthy volunteers. RINSHO IYAKU (written in Japanese). 2000;16:1531–1556
  40. Hasuo H, Tomiyasu S, Hojo M. Effect of ONO-1101, a novel short-acting beta-blocker, on hemodynamic responses to isoflurane inhalation and tracheal intubation. J Anesth. 1998;12:115–118
  41. Kitamura A, Sakamoto A, Inoue T, Ogawa R. Efficacy of an ultra-short-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur J Clin Pharmacol. 1997;51:467–471
  42. Fernandez-Galinski S, Bermejo S, Mansilla R, Pol O, Puig MM. Comparative assessment of the effects of alfentanil, esmolol or clonidine when used as adjuvants during induction of general anesthesia. Eur J Anaesthesiol. 2004;21:476–482
  43. Cheney FW, Posner KL, Caplan RA. Adverse respiratory events infrequently leading to malpractice suits. Anesthesiology. 1991;75:932–939
  44. Caplan RA, Posner KL, Ward RJ, Cheney FW. Adverse respiratory events in anesthesia (A closed claims analysis). Anesthesiology. 1990;72:828–833
  45. Warner DO, Warner MA, Barnes RD. Perioperative respiratory complications in patients with asthma. Anesthesiology. 1996;85:460–467
  46. Wajima Z, Yoshikawa T, Ogura A. Intravenous colforsin daropate, a water-soluble forskolin derivative, prevents thiamylal-fentanyl-induced bronchoconstriction in humans. Crit Care Med. 2002;30:820–826
  47. Manning MM, Broadstone RV. Effects of alpha2-adrenergic receptor agonist and antagonist drugs on cholinergic contraction in bovine tracheal smooth muscle in vitro. Am J Vet Res. 1995;56:930–935
  48. Groeben H, Mitzner W, Brown RH. Effects of the alpha2-adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs. Anesthesiology. 2004;100:359–363
  49. Yamakage M, Iwasaki S, Jeong S-W, Namiki A. Effects of alpha2-adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs. Anesthesiology. 2004;101:A1585

 Supported by a grant-in-aid (No. 15591648, 2003∼2005) for research from the Ministry of Education, Science and Culture, Tokyo, Japan, and an incentive grant (No. B-15, 2003) for research from the Japan Medical Association, Tokyo, Japan.

PII: S0147-9563(08)00014-9

doi: 10.1016/j.hrtlng.2008.01.002

Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 1 , Pages 48-55 , January 2009

Article Tools

* Image Usage & Resolution